Alternatively, Ren et al. (50) observed a reduction in enzymes involved in cholesterol biosynthesis pathway (Cyp51A1 and Sc4mol (MSM01)), as well as a decrease of cholesterol content in astrocytes from human FXS-derived induced pluripotent stem cells (hiPSCs). The gene discussed is CYP51A1; the disease is fragile X syndrome.